Exchange: NASDAQ·Updated 07:43 PM EDT
News
all
press releases
BillionToOne's Co-Founder Sells 10,000 Shares for $1 Million
Key PointsThe transaction involved 10,000 shares at a weighted-average price of $100.00 per share, totaling $1.0 million on the August 25, 2026 transaction date...
Nasdaq News: Markets
More News
Jim Cramer: 'You Could Make Some Money With This 5.6% Yield'
Jim Cramer likes Babcock & Wilcox and Smithfield Foods. He also advises taking some profits on BillionToOne, and calls Eton Pharma a winner.read more...
Benzinga
Largest Prospective Study in General-Risk Pregnancies Strengthens Evidence for cfDNA Fetal Risk Assessment as a Primary Screen for Recessive Conditions
Largest Prospective Study in General-Risk Pregnancies Strengthens Evidence for cfDNA Fetal Risk Assessment as a Primary Screen for Recessive Conditions Largest Prospective Study in General-Risk Pregnancies Strengthens Evidence for cfDNA Fetal Risk Assessment as a Primary Screen for Recessive...
PR Newswire
BillionToOne (BLLN) Q2 2026 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
BillionToOne (BLLN) Reports Q2 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for BillionToOne (BLLN) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Zacks
Does BillionToOne (BLLN) Have Another Major Growth Engine Beyond Prenatal Testing?
Does?BillionToOne?(BLLN) Have Another Major Growth Engine Beyond Prenatal Testing...
Yahoo! Finance: News
BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar
BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar PR Newswire MENLO PARK, Calif., July 20, 2026 Renowned...
PR Newswire
A BillionToOne Insider Sold 801 Shares as Revenue Jumped 84%
Key PointsAccording to a Form 4 filing, a BillionToOne executive sold 801 shares of Class A Common Stock at $124.91 per share for a total transaction value of $100,053 on July 1, 2026...
Nasdaq News: Markets
Billiontoone Reaches Analyst Target Price
In recent trading, shares of Billiontoone Inc (Symbol: BLLN) have crossed above the average analyst 12-month target price of $118.43, changing hands for $120.60/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on v...
Nasdaq News: Markets
Are Medical Stocks Lagging BillionToOne, Inc. (BLLN) This Year?
Here is how BillionToOne (BLLN) and Concentra Group (CON) have performed compared to their sector so far this year.
Zacks

Advertisement|Remove ads.